Peptide Stack
Fat Loss GH
Tesamorelin + Ipamorelin
Stack purpose
Visceral fat reduction + GH pulse
Stack components (2)
- Tesamorelin , GHRH analog (FDA-approved) · FDA-Approved · 165 citations
- Ipamorelin , Growth hormone-releasing peptide (GHRP); ghrelin receptor agonist · Anecdotal + Phase 2 · 91 citations
Mechanism, how the components interact
Tesamorelin (FDA-approved GHRH) reduces visceral adiposity; Ipamorelin amplifies pulsatile GH release
Typical use in research and practitioner literature
Body recomposition targeting visceral fat
Reported research use only. Not a clinical recommendation. Consult a qualified clinician before any human use.
Notes
Tesamorelin is the only FDA-approved GHRH; the combination is off-label
Frequently asked questions
What is the purpose of the Fat Loss GH stack?
Visceral fat reduction + GH pulse.
How do the peptides in Fat Loss GH work together?
Tesamorelin (FDA-approved GHRH) reduces visceral adiposity; Ipamorelin amplifies pulsatile GH release
When is the Fat Loss GH stack typically used in research?
Body recomposition targeting visceral fat
What should I know about the Fat Loss GH stack?
Tesamorelin is the only FDA-approved GHRH; the combination is off-label
What peptides are in the Fat Loss GH stack?
Tesamorelin + Ipamorelin.
Open the interactive stack evaluator on PeptideHelper.org to model this combination, check class-level conflicts, and substitute components.
Loading interactive view…